BELGRADE, Mont. and DALLAS, June 08, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices and Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions, today announced a joint agreement to expand distribution of Pinnacle’s InFill® Lateral Lumbar Interbody Fusion System. Through this agreement, Xtant enters the lateral lumbar interbody fusion market, expanding its spinal hardware portfolio.
The foundation of Pinnacle Spine Group’s complete InFill fusion systems is its patented ability to deliver bone graft material to the fusion device in situ. The unique features of the InFill Lateral Fusion device combined with the InFill Graft Delivery System provide the opportunity for a more robust fusion column and maximized bone graft-to-endplate contact. The InFill Lateral Lumbar Interbody Fusion system is intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1.
“We are excited to partner with Xtant Medical, a recognized industry leader, to bring new and innovative solutions to spine surgeons,” said Zach Sowell, President of Pinnacle Spine Group. “Our patented innovative technology offers a terrific platform for Xtant and Pinnacle to grow their core competencies and expand their scope in the spinal fusion segment.”
“It is a very exciting time for Xtant Medical as we continue to broaden our portfolio. This system will allow Xtant Medicalto meet the needs of orthopedic and neuro spine surgeons who currently practice minimally invasive spine surgery or looking to expand their procedural options,” stated Dr. David Kirschman, Executive Vice President and Chief Scientific Officer.
According to iData Research, it is estimated that the US market for lateral lumber interbody fusion in 2015 was nearly$254M and is expected to be close to $309M in 2020.